NRXP
NRX Pharmaceuticals, Inc. - Common Stock (NRXP)
$27
About NRX Pharmaceuticals, Inc. - Common Stock (NRXP)
NRX Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded by Jonathan C. Javitt on September 18, 2017 and is headquartered in Wilmington, DE.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$5.06
52 Week Low
$1.62
Market cap
107.8M
Dividend yield
-
Volume
4,345
Avg. volume
1.7M
P/E ratio
-3.38
NRX Pharmaceuticals, Inc. - Common Stock News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$5.06
52 Week Low
$1.62
Market cap
107.8M
Dividend yield
-
Volume
4,345
Avg. volume
1.7M
P/E ratio
-3.38